Details for New Drug Application (NDA): 091246
✉ Email this page to a colleague
The generic ingredient in OXACILLIN SODIUM is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Summary for 091246
Tradename: | OXACILLIN SODIUM |
Applicant: | Sagent Pharms |
Ingredient: | oxacillin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 091246
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 091246 | ANDA | Sagent Pharmaceuticals | 25021-146 | 25021-146-10 | 10 VIAL in 1 CARTON (25021-146-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
OXACILLIN SODIUM | oxacillin sodium | INJECTABLE;INJECTION | 091246 | ANDA | Sagent Pharmaceuticals | 25021-162 | 25021-162-24 | 10 VIAL in 1 CARTON (25021-162-24) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Mar 30, 2012 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Mar 30, 2012 | TE: | AP | RLD: | No |
Complete Access Available with Subscription